Previous studies have chiefly demonstrated the potential value of traditional biomarkers for diagnosing and predicting the occurrence of IPN, such as the APACHE II score, CRP, PCT, and other biomarkers [10, 28, 29]. The gene discussed is CRP; the disease is bile duct papillary neoplasm.